A novel assocation between HLA and disease: porphyria cutanea tarda and HLA-AW32

Area of Science:

• Immunogenetics
• Dermatology
• Genetic Epidemiology

Background:

• Porphyria cutanea tarda (PCT) is the most common type of porphyria, a group of genetic and acquired disorders of heme biosynthesis.
• Human Leukocyte Antigen (HLA) genes play a crucial role in immune response and have been associated with various autoimmune and genetic conditions.

Purpose of the Study:

• To investigate a potential association between porphyria cutanea tarda and specific Human Leukocyte Antigen (HLA) types.
• To determine if HLA-AW32 is a risk factor for developing porphyria cutanea tarda.

Main Methods:

• A case-control study was conducted involving 28 unrelated patients diagnosed with porphyria cutanea tarda.
• A control group of 148 individuals was used for comparison.
• HLA-AW32 antigen typing was performed on both patient and control groups.

Main Results:

• A statistically significant association was observed between porphyria cutanea tarda and the presence of the HLA-AW32 antigen.
• The relative risk (RR) for developing porphyria cutanea tarda in individuals with HLA-AW32 was calculated to be 3.09.
• The chi-squared test yielded a value of 4.55, with a p-value less than 0.05, indicating statistical significance.

Conclusions:

• The findings suggest that the HLA-AW32 antigen may be a genetic susceptibility factor for porphyria cutanea tarda.
• Further research is warranted to elucidate the underlying mechanisms of this association.